Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 0.77% is 174% above its 2-year average of 0.28%, near the high end of its 2-year range (0.05%–0.77%).
As of the fiscal period ended Tuesday, June 30, 2026. 158.89% above its 12-month average of 0.30%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.77%.
DEBT TO ASSETS RATIO
0.77%
DEBT TO ASSETS RATIO AVG TTM
0.30%
DEBT TO ASSETS RATIO AVG 3Y
N/A
DEBT TO ASSETS RATIO AVG 5Y
N/A
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+158.89%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+751.60%
vs the sector median at left
MBX Biosciences, Inc. Common Stock
Market Cap
$2.66B
Debt to Assets Ratio
0.77%
TTM Avg
0.30%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.66B
Debt to Assets Ratio
0.71%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.68B
Debt to Assets Ratio
0.46%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.62B
Debt to Assets Ratio
0.18%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.57B
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.53B
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MBX Biosciences, Inc. Common Stock (MBX) | $2.66B | 0.77% | 0.30% | N/A | N/A |
| Neogen Corporation (NEOG)vs › | $2.65B | 0.24% | N/A | N/A | N/A |
| Aveanna Healthcare Holdings Inc. (AVAH)vs › | $2.66B | 0.71% | N/A | N/A | N/A |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.68B | 0.46% | N/A | N/A | N/A |
| Beam Therapeutics Inc. (BEAM)vs › | $2.62B | 0.18% | N/A | N/A | N/A |
| Precigen, Inc. (PGEN)vs › | $2.73B | 0.58% | N/A | N/A | N/A |
| Privia Health Group, Inc. (PRVA)vs › | $2.57B | 0.01% | N/A | N/A | N/A |
| AtriCure, Inc. (ATRC)vs › | $2.78B | 0.11% | N/A | N/A | N/A |
| NewAmsterdam Pharma Company N.V. (NAMS)vs › | $2.53B | 0.00% | N/A | N/A | N/A |
| TransMedics Group, Inc. (TMDX)vs › | $2.80B | 0.59% | N/A | N/A | N/A |
Debt/Assets
0.8%
Debt/Equity
0.01
Current Ratio
18.08
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 0.77% |
| 2026-03-31 | 0.12% |
| 2025-12-31 | 0.15% |
| 2025-09-30 | 0.16% |
| 2025-06-30 | 0.28% |
| 2025-03-31 | 0.05% |
| 2024-12-31 | 0.06% |
| 2024-09-30 | 0.07% |
| 2024-06-30 | 0.40% |
| 2024-03-31 | 0.63% |
| 2023-12-31 | 0.38% |
